[SLRX] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
12-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 14.40%
YoY- -28.81%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 1,269 1,479 1,378 1,243 1,133 1,039 875 28.09%
PBT -1,852 -1,768 -1,717 -1,784 -2,084 -1,882 -2,630 -20.83%
Tax 47 10 -42 62 -286 1 -2 -
NP -1,852 -1,768 -1,717 -1,784 -2,084 -1,883 -2,628 -20.79%
Tax Rate - - - - - - - -
Total Cost 3,121 3,246 3,095 3,028 3,217 2,922 3,503 -7.40%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -145.95 -119.52 -124.55 -143.51 -183.95 -181.27 -300.33 -38.16%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -1.52 -2.84 -2.39 -3.20 -5.46 -14.40 -18.22 -80.87%
EPS Diluted -1.52 -2.84 -2.39 -3.20 -5.46 -14.40 -18.22 -80.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.